Publications

Oncogene

A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator.

28-07-2026

Clinical pharmacokinetics

Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054/COG AAML1921) and Pediatric Recommended Phase II Dosage Evaluation.

27-07-2026

European journal of cancer (Oxford, England : 1990)

Papillary renal cell carcinoma - exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review.

26-07-2026

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

External validation of dose to heart substructures and the association with non-cancer death after SBRT in stage I-II NSCLC patients.

26-07-2026

Seminars in cancer biology

Beyond the traditional dish: Advanced 3D ex vivo culture platforms for tumor modelling.

24-07-2026

Journal of the National Cancer Institute

Clarifying risk-factor associations with quantitative breast tumor features: a pooled analysis of 24 studies.

24-07-2026

European journal of cancer (Oxford, England : 1990)

International phase IV field study to validate the European Organisation for Research and Treatment of Cancer questionnaire for assessing the health-related quality of life of cancer survivors: The EORTC QLQ-SURV100.

22-07-2026

European journal of cancer (Oxford, England : 1990)

The European Organisation for Research and Treatment of Cancer Quality of Life Group: Past achievements and future priorities in patient-reported outcomes in oncology.

22-07-2026

Cell reports methods

Efficient generation of human cDC1-like cells to detect and enhance tumor-reactive T cells via CD4⁺ T cell help.

22-07-2026

Journal of occupational rehabilitation

Health- and Work-Related Outcomes in Partners of Cancer Survivors: A Prospective Cohort Study.

21-07-2026

European journal of nuclear medicine and molecular imaging

LiDAR-registered freehand SPECT combined with NIR-fluorescence enables spatial localisation of tracer-avid inguinal lymph nodes: A clinical feasibility study.

21-07-2026

Cell reports. Medicine

Tryptophan degradation by intestinal Bacteroides induces anti-tumor immunity and limits melanoma growth.

21-07-2026

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Reply to: In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid Tumors.

20-07-2026

Journal of occupational rehabilitation

SusTained Employability in cancer Patients and their partnerS: Results of a Randomized Controlled Trial into the Effectiveness of the STEPS Program.

20-07-2026

Journal of occupational rehabilitation

Cost-Effectiveness of the STEPS Work Participation Program Compared to Usual Care, for Cancer Survivors: An Economic Evaluation Alongside a Randomized Controlled Trial.

20-07-2026

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Development and validation of an LC-MS/MS method for the quantification of the KRAS^G12C inhibitor divarasib.

18-07-2026

Cancer treatment and research communications

Fumarate hydratase-deficient renal cell carcinoma - results of the exploratory analysis in the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line treatment.

18-07-2026

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Brief report: Reducing Lorlatinib-related Adverse Events by establishing the Optimal Exposure-Toxicity Threshold in Patients with NSCLC.

16-07-2026

Cancer research

Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production.

15-07-2026

Journal of cancer survivorship : research and practice

Knowledge gaps among adult Hodgkin lymphoma survivors: implications for risk‑based care.

15-07-2026

Trends in cancer

Neoadjuvant immunotherapy in breast cancer: Progress and challenges.

15-07-2026

Clinical cancer research : an official journal of the American Association for Cancer Research

The pharmacological profile of ART6043, a first-in-class clinical DNA polymerase theta polymerase domain inhibitor potentiating PARP inhibitor efficacy.

13-07-2026

Cancer cell

Targeting tumor-intrinsic STK40 induces immune vulnerability and drives T cell reinvigoration.

13-07-2026

European journal of nuclear medicine and molecular imaging

Real-world use of PSMA imaging in metastatic castration-sensitive prostate cancer: Findings from the CAPRI-3 registry.

10-07-2026

Journal of the National Cancer Institute

Neoadjuvant immunotherapy for resectable cutaneous melanoma: a nationwide population-based cohort.

10-07-2026

The EMBO journal

Alterations in chromatin organization promote totipotent-like features in a DPPA2/DUX-dependent manner.

09-07-2026

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Still Lost in Transition? A 20-Year Reflection on Cancer Survivorship Care.

08-07-2026

European urology oncology

MRI-based Response Assessment of Neoadjuvant Systemic Immunotherapy in Muscle-invasive Bladder Cancer: An Analysis of Inter-radiologist Variability and Diagnostic Accuracy in three Prospective Clinical Trials.

08-07-2026

Cell chemical biology

XPO1 inhibition induces NCOR1-Dependent oxidative stress to suppress hepatocellular carcinoma.

07-07-2026

Cancer chemotherapy and pharmacology

The use of pharmacodynamic results for recommended phase II decision making in oncology clinical trials.

06-07-2026

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Self-reported peripheral neuropathic symptoms in long-term adolescent and young adult (AYA) cancer survivors: results of the SURVAYA study.

02-07-2026

Cancer discovery

Germline CDK12 variants in aggressive prostate cancer.

02-07-2026

European journal of nuclear medicine and molecular imaging

Redefining robotic image-guidance - tomographic visualization of lesions during prostate cancer surgery via gantry-free robotic SPECT.

01-07-2026

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Human epididymis protein 4 and risk of malignancy index as risk assessment tools in the decision for referral to an oncology center in patients with an ovarian mass: a cost-effectiveness analysis from a Dutch health care perspective.

01-07-2026

Pharmacological research

Daraxonrasib (RMC-6236) pharmacokinetics: impact of transporters and drug-metabolizing enzymes on a first-in-class pan-RAS molecular glue.

01-07-2026

Transplantation and cellular therapy

Advancing Cell Therapies for Solid Tumors: A Pathway to Overcome Biological, Operational, and Regulatory Hurdles.

01-07-2026

Radiology. Artificial intelligence

Tumor-preserving Deformable Registration of Longitudinal DCE Breast MRI during Neoadjuvant Chemotherapy.

01-07-2026

Nature

TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancer.

01-07-2026

Radiology

Contrast-enhanced Mammography for Breast Cancer Screening in Women at Increased Risk: Comparison of Prevalence and Incidence Screens.

01-07-2026

Neuro-oncology advances

Cancer treatment-related cognitive impairment.

01-07-2026

Clinical and translational radiation oncology

Predicting locoregional treatment failure in anal cancer using multivariable clinical-imaging models.

01-07-2026

European urology open science

Corrigendum to "Long-term real-world survival outcomes with dual immune checkpoint blockade in synchronous metastatic renal cell carcinoma: implications for the design of prospective cytoreductive nephrectomy trials" [Eur. Urol. Open Sci. 83 (2026) 133-141].

01-07-2026

European urology

European Association of Urology and American Society of Clinical Oncology Guidelines on Penile Cancer: A Summary of the 2026 Guidelines Update.

01-07-2026

Radiography (London, England : 1995)

Independent patient access to imaging digital health records: Oncology patients' and healthcare professionals' views and preferences.

01-07-2026

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Diffusion weighted MRI-based hypoxic fraction as a prognostic factor in the FLAME trial prostate cancer cohort.

01-07-2026

Trends in cancer

Watching cancer begin: emerging tools to visualize the first steps of tumorigenesis.

01-07-2026

Annals of surgical oncology

Understanding Physical Functioning in Patients with Sarcoma After Amputation: Using an International Classification of Functioning, Disability and Health (ICF) Approach.

01-07-2026

The Lancet. Oncology

Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial.

01-07-2026

Thyroid : official journal of the American Thyroid Association

Prospective Predictors of Poor Emotional Functioning in Patients with Differentiated Thyroid Carcinoma.

01-07-2026

Nature genetics

Insights from three decades of BRCA1/2 modeling in mice.

01-07-2026

A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator.

Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054/COG AAML1921) and Pediatric Recommended Phase II Dosage Evaluation.

Papillary renal cell carcinoma - exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review.

External validation of dose to heart substructures and the association with non-cancer death after SBRT in stage I-II NSCLC patients.

Beyond the traditional dish: Advanced 3D ex vivo culture platforms for tumor modelling.

Clarifying risk-factor associations with quantitative breast tumor features: a pooled analysis of 24 studies.

International phase IV field study to validate the European Organisation for Research and Treatment of Cancer questionnaire for assessing the health-related quality of life of cancer survivors: The EORTC QLQ-SURV100.

The European Organisation for Research and Treatment of Cancer Quality of Life Group: Past achievements and future priorities in patient-reported outcomes in oncology.

Efficient generation of human cDC1-like cells to detect and enhance tumor-reactive T cells via CD4+ T cell help.

Health- and Work-Related Outcomes in Partners of Cancer Survivors: A Prospective Cohort Study.

LiDAR-registered freehand SPECT combined with NIR-fluorescence enables spatial localisation of tracer-avid inguinal lymph nodes: A clinical feasibility study.

Tryptophan degradation by intestinal Bacteroides induces anti-tumor immunity and limits melanoma growth.

Reply to: In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid Tumors.

SusTained Employability in cancer Patients and their partnerS: Results of a Randomized Controlled Trial into the Effectiveness of the STEPS Program.

Cost-Effectiveness of the STEPS Work Participation Program Compared to Usual Care, for Cancer Survivors: An Economic Evaluation Alongside a Randomized Controlled Trial.

Development and validation of an LC-MS/MS method for the quantification of the KRASG12C inhibitor divarasib.

Fumarate hydratase-deficient renal cell carcinoma - results of the exploratory analysis in the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line treatment.

Brief report: Reducing Lorlatinib-related Adverse Events by establishing the Optimal Exposure-Toxicity Threshold in Patients with NSCLC.

Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production.

Knowledge gaps among adult Hodgkin lymphoma survivors: implications for risk‑based care.

Neoadjuvant immunotherapy in breast cancer: Progress and challenges.

The pharmacological profile of ART6043, a first-in-class clinical DNA polymerase theta polymerase domain inhibitor potentiating PARP inhibitor efficacy.

Targeting tumor-intrinsic STK40 induces immune vulnerability and drives T cell reinvigoration.

Real-world use of PSMA imaging in metastatic castration-sensitive prostate cancer: Findings from the CAPRI-3 registry.

Neoadjuvant immunotherapy for resectable cutaneous melanoma: a nationwide population-based cohort.

Alterations in chromatin organization promote totipotent-like features in a DPPA2/DUX-dependent manner.

Still Lost in Transition? A 20-Year Reflection on Cancer Survivorship Care.

MRI-based Response Assessment of Neoadjuvant Systemic Immunotherapy in Muscle-invasive Bladder Cancer: An Analysis of Inter-radiologist Variability and Diagnostic Accuracy in three Prospective Clinical Trials.

XPO1 inhibition induces NCOR1-Dependent oxidative stress to suppress hepatocellular carcinoma.

The use of pharmacodynamic results for recommended phase II decision making in oncology clinical trials.

Self-reported peripheral neuropathic symptoms in long-term adolescent and young adult (AYA) cancer survivors: results of the SURVAYA study.

Germline CDK12 variants in aggressive prostate cancer.

Redefining robotic image-guidance - tomographic visualization of lesions during prostate cancer surgery via gantry-free robotic SPECT.

Human epididymis protein 4 and risk of malignancy index as risk assessment tools in the decision for referral to an oncology center in patients with an ovarian mass: a cost-effectiveness analysis from a Dutch health care perspective.

Daraxonrasib (RMC-6236) pharmacokinetics: impact of transporters and drug-metabolizing enzymes on a first-in-class pan-RAS molecular glue.

Advancing Cell Therapies for Solid Tumors: A Pathway to Overcome Biological, Operational, and Regulatory Hurdles.

Tumor-preserving Deformable Registration of Longitudinal DCE Breast MRI during Neoadjuvant Chemotherapy.

TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancer.

Contrast-enhanced Mammography for Breast Cancer Screening in Women at Increased Risk: Comparison of Prevalence and Incidence Screens.

Cancer treatment-related cognitive impairment.

Predicting locoregional treatment failure in anal cancer using multivariable clinical-imaging models.

Corrigendum to "Long-term real-world survival outcomes with dual immune checkpoint blockade in synchronous metastatic renal cell carcinoma: implications for the design of prospective cytoreductive nephrectomy trials" [Eur. Urol. Open Sci. 83 (2026) 133-141].

European Association of Urology and American Society of Clinical Oncology Guidelines on Penile Cancer: A Summary of the 2026 Guidelines Update.

Independent patient access to imaging digital health records: Oncology patients' and healthcare professionals' views and preferences.

Diffusion weighted MRI-based hypoxic fraction as a prognostic factor in the FLAME trial prostate cancer cohort.

Watching cancer begin: emerging tools to visualize the first steps of tumorigenesis.

Understanding Physical Functioning in Patients with Sarcoma After Amputation: Using an International Classification of Functioning, Disability and Health (ICF) Approach.

Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial.

Prospective Predictors of Poor Emotional Functioning in Patients with Differentiated Thyroid Carcinoma.

Insights from three decades of BRCA1/2 modeling in mice.

This site uses cookies

Efficient generation of human cDC1-like cells to detect and enhance tumor-reactive T cells via CD4⁺ T cell help.

Development and validation of an LC-MS/MS method for the quantification of the KRAS^G12C inhibitor divarasib.